GILD:NSD-Gilead Sciences Inc (USD)

COMMON STOCK | Drug Manufacturers - General |

Last Closing

USD 107.25

Change

0.00 (0.00)%

Market Cap

USD 133.70B

Volume

0.01B

Analyst Target

USD 77.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-06 )

Largest Industry Peers for Drug Manufacturers - General

Symbol Name Price(Change) Market Cap
AZN AstraZeneca PLC ADR

N/A

USD 240.59B
AMGN Amgen Inc

N/A

USD 164.90B
SNY Sanofi ADR

N/A

USD 148.55B
BIIB Biogen Inc

N/A

USD 18.00B
GRFS Grifols SA ADR

N/A

USD 7.13B
AMRN Amarin Corporation PLC

N/A

USD 0.19B
MIRA MIRA Pharmaceuticals, Inc. Com..

N/A

USD 0.02B
SCLX Scilex Holding Company

N/A

N/A
SCLXW Scilex Holding Company

N/A

N/A

ETFs Containing GILD

BTEC:SW iShares Nasdaq US Biotech.. 8.25 % 0.00 %

N/A

N/A
UBIO 7.77 % 0.95 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 5.90 % 0.00 %

N/A

CAD 0.05B
HDLB ETRACS Monthly Pay 2xLeve.. 5.14 % 0.00 %

N/A

USD 8.34M
KNGU:CA Brompton U.S. Cash Flow K.. 4.34 % 0.00 %

N/A

CAD 0.01B
UDI USCF ETF Trust 4.00 % 0.00 %

N/A

N/A
TBG EA Series Trust 3.96 % 0.00 %

N/A

USD 0.12B
JPHG:PA Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

N/A
JPHC:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 4.62M
JPHE:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPHG:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 3.59M
JPHU:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.06B
JPNK:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 0.07B
JPNY:SW Amundi Index Solutions - .. 3.90 % 0.00 %

N/A

USD 6.26B
SAMM The Advisors’ Inner .. 3.69 % 0.00 %

N/A

USD 0.02B
MOTV:LSE VanEck Morningstar US Wid.. 3.48 % 0.00 %

N/A

USD 0.06B
QNXT iShares Nasdaq-100 ex Top.. 3.45 % 0.00 %

N/A

USD 0.01B
MHOT:AU VanEck Morningstar Wide M.. 3.42 % 0.00 %

N/A

N/A
MOAT:AU VanEck Morningstar Wide M.. 3.41 % 0.00 %

N/A

USD 1.04B
CBUF:F iShares V Public Limited .. 3.37 % 0.00 %

N/A

N/A
MDLV EA Series Trust - Morgan .. 3.19 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.19 % 0.00 %

N/A

N/A
CURE:AU ETFS S&P Biotech ETF 3.02 % 0.00 %

N/A

USD 0.04B
QQQG Pacer Nasdaq 100 Top 50 C.. 2.89 % 0.00 %

N/A

USD 2.39M
MOTU:LSE VanEck Morningstar US Wid.. 2.76 % 0.00 %

N/A

USD 0.06B
BMED BlackRock Future Health E.. 2.73 % 0.00 %

N/A

USD 2.67M
INVN The Alger ETF Trust 2.69 % 0.00 %

N/A

N/A
HEAL:SW iShares Healthcare Innova.. 2.67 % 0.00 %

N/A

USD 1.05B
QUVU Hartford Quality Value ET.. 2.66 % 0.00 %

N/A

USD 0.16B
WMOT:XETRA VanEck Morningstar US Wid.. 2.51 % 0.00 %

N/A

N/A
ZYUS:AU ANZ S&P 500 High Yield Lo.. 2.38 % 0.00 %

N/A

USD 0.08B
TDOC:CA TD Global Healthcare Lead.. 2.35 % 0.00 %

N/A

CAD 0.08B
HWVS:LSE HSBC MSCI World Value ESG.. 2.25 % 0.00 %

N/A

USD 0.23B
FLCV Federated Hermes ETF Trus.. 2.21 % 0.00 %

N/A

USD 0.03B
RAYD Rayliant Quantitative Dev.. 2.18 % 0.00 %

N/A

USD 0.09B
ABFL Abacus FCF Leaders ETF 2.16 % 0.00 %

N/A

N/A
DHS:SW 2.04 % 0.00 %

N/A

N/A
DHSA:SW WisdomTree US Equity Inco.. 2.04 % 0.00 %

N/A

N/A
CBUI:XETRA iShares MSCI World Value .. 1.96 % 0.00 %

N/A

USD 0.26B
INCM:AU BetaShares Global Income .. 1.80 % 0.00 %

N/A

USD 0.03B
ESMV iShares ESG MSCI USA Min .. 1.73 % 0.00 %

N/A

USD 8.61M
AVLV American Century ETF Trus.. 1.69 % 0.00 %

N/A

USD 5.70B
DIVG Invesco Exchange-Traded F.. 1.69 % 0.00 %

N/A

USD 3.32M
VMAX REX VolMAXX Long VIX Futu.. 1.67 % 0.00 %

N/A

USD 0.04B
IQSA:LSE Invesco Quantitative Stra.. 1.61 % 0.00 %

N/A

USD 0.79B
MVEW:LSE iShares Edge MSCI World M.. 1.57 % 0.00 %

N/A

USD 0.46B
ZLU-U:CA BMO Low Volatility US Equ.. 1.57 % 0.00 %

N/A

N/A
CSY9:XETRA UBS (Irl) ETF plc - Facto.. 1.52 % 0.00 %

N/A

USD 0.29B
MVEC:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.50B
MVWE:SW iShares Edge MSCI World M.. 1.46 % 0.00 %

N/A

USD 0.07B
AFLG First Trust Active Factor.. 1.31 % 0.00 %

N/A

USD 0.22B
QQEQ:CA Invesco NASDAQ 100 Equal .. 1.20 % 0.00 %

N/A

CAD 0.01B
FLSP Franklin Liberty Systemat.. 1.04 % 0.00 %

N/A

USD 0.31B
DGVA:AU Dimensional Global Value .. 1.00 % 0.00 %

N/A

N/A
HLGE Hartford Longevity Econom.. 0.99 % 0.00 %

N/A

USD 0.01B
EVO:CA Evovest Global Equity ETF 0.96 % 0.00 %

N/A

N/A
RSPE Invesco Exchange-Traded F.. 0.73 % 0.00 %

N/A

USD 0.02B
PAPI Morgan Stanley ETF Trust 0.66 % 0.00 %

N/A

USD 0.16B
WELE:XETRA Amundi S&P 500 Equal Weig.. 0.59 % 0.00 %

N/A

N/A
TSWE:SW VanEck Sustainable World .. 0.57 % 0.00 %

N/A

USD 0.93B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.45 % 0.00 %

N/A

USD 2.73B
JPGL:SW JPM Global Equity Multi-F.. 0.38 % 0.00 %

N/A

N/A
XDEE:XETRA Xtrackers S&P 500 Equal W.. 0.25 % 0.00 %

N/A

USD 12.74B
ISPE:LSE iShares S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

USD 0.73B
EWSX:LSE iShares S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

N/A
SP2D:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

USD 0.21B
SP2Q:XETRA Invesco S&P 500 Equal Wei.. 0.25 % 0.00 %

N/A

USD 1.55B
BBH VanEck Biotech ETF 0.00 % 0.35 %

N/A

USD 0.40B
BIB ProShares Ultra Nasdaq Bi.. 0.00 % 0.95 %

N/A

USD 0.06B
BIS ProShares UltraShort Nasd.. 0.00 % 0.95 %

N/A

USD 3.28M
BSCK 0.00 % 0.10 %

N/A

N/A
BSCL 0.00 % 0.10 %

N/A

N/A
BSCQ Invesco BulletShares 2026.. 0.00 % 0.10 %

N/A

N/A
CBND 0.00 % 0.16 %

N/A

N/A
CYH:CA iShares Global Monthly Di.. 0.00 % 0.66 %

N/A

CAD 0.15B
DVP Roundhill Acquirers Deep .. 0.00 % 0.48 %

N/A

N/A
ESGW 0.00 % 0.40 %

N/A

N/A
EUSA iShares MSCI USA Equal We.. 0.00 % 0.15 %

N/A

USD 1.21B
FCY 0.00 % 0.84 %

N/A

N/A
FCY:CA 0.00 % 0.95 %

N/A

N/A
FDL First Trust Morningstar D.. 0.00 % 0.45 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

N/A

USD 6.00B
IBCD 0.00 % 0.10 %

N/A

N/A
LABU Direxion Daily S&P Biotec.. 0.00 % 1.14 %

N/A

USD 0.66B
MOAT VanEck Morningstar Wide M.. 0.00 % 0.49 %

N/A

N/A
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

N/A
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

N/A
PBE Invesco Dynamic Biotechno.. 0.00 % 0.57 %

N/A

N/A
QQEW First Trust NASDAQ-100 Eq.. 0.00 % 0.60 %

N/A

USD 1.81B
QQXT First Trust NASDAQ-100 Ex.. 0.00 % 0.60 %

N/A

USD 0.11B
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
VSL 0.00 % 0.65 %

N/A

N/A
JIGB 0.00 % 0.14 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.01B
SPBO SPDR Portfolio Corporate .. 0.00 % 0.00 %

N/A

USD 1.80B
BTEC:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEK:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
BTEE:LSE iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

N/A
RJZ 0.00 % 0.75 %

N/A

N/A
SCIU 0.00 % 0.19 %

N/A

N/A
SICK 0.00 % 0.95 %

N/A

N/A
WBIL WBI BullBear Quality 3000.. 0.00 % 1.07 %

N/A

USD 0.03B
XBI SPDR® S&P Biotech ETF 0.00 % 0.35 %

N/A

N/A
XMS:CA iShares Edge MSCI Min Vol.. 0.00 % 0.33 %

N/A

N/A
ZBIO Zenas BioPharma, Inc. Com.. 0.00 % 0.95 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

N/A

CAD 0.22B
LIFE:CA Evolve Global Healthcare .. 0.00 % 0.69 %

N/A

CAD 0.22B
FCW:CA 0.00 % 0.90 %

N/A

N/A
DHS:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSA:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSD:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSG:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DHSP:LSE WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
DRDR:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
HEAL:LSE iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XFVT:LSE Xtrackers FTSE Vietnam Sw.. 0.00 % 0.00 %

N/A

N/A
JPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 4.52M
UBBB:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.13B
2B70:F iShares NASDAQ US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
JP40:F Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:F 0.00 % 0.00 %

N/A

N/A
WTD9:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.06B
WTDY:F WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

USD 1.44M
WTEU:F WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

USD 0.11B
2B70:XETRA iShares Nasdaq US Biotech.. 0.00 % 0.00 %

N/A

USD 0.52B
2B78:XETRA iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

USD 1.05B
JP40:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

N/A
JP4H:XETRA 0.00 % 0.00 %

N/A

N/A
WTD9:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

N/A
WTDY:XETRA WisdomTree Issuer ICAV - .. 0.00 % 0.00 %

N/A

N/A
WTEU:XETRA WisdomTree US Equity Inco.. 0.00 % 0.00 %

N/A

N/A
ZGEN:CA 0.00 % 0.00 %

N/A

N/A
ZINN:CA 0.00 % 0.00 %

N/A

N/A
JPGL:XETRA JPM Global Equity Multi-F.. 0.00 % 0.00 %

N/A

N/A
MVEW:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
SCHJ Schwab 1-5 Year Corporate.. 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

N/A

N/A
FBT:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 8.62M
FBTU:LSE First Trust Global Funds .. 0.00 % 0.00 %

N/A

USD 8.52M
IBBQ Invesco Nasdaq Biotechnol.. 0.00 % 0.00 %

N/A

USD 0.04B
2B78:F iShares Healthcare Innova.. 0.00 % 0.00 %

N/A

N/A
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

N/A

N/A
GDOC Goldman Sachs ETF Trust 0.00 % 0.00 %

N/A

USD 0.02B
WDMVO:SW UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

N/A

USD 0.29B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - General) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.11% 100% F 92% A
Dividend Return 0.86% 33% F 57% F
Total Return 16.96% 100% F 92% A
Trailing 12 Months  
Capital Gain 54.14% 100% F 93% A
Dividend Return 4.46% 100% F 75% C
Total Return 58.59% 100% F 94% A
Trailing 5 Years  
Capital Gain 43.63% 86% B+ 62% D
Dividend Return 19.65% 80% B- 57% F
Total Return 63.28% 86% B+ 63% D
Average Annual (5 Year Horizon)  
Capital Gain 3.40% 80% B- 51% F
Dividend Return 6.99% 80% B- 56% F
Total Return 3.59% 80% B- 74% C
Risk Return Profile  
Volatility (Standard Deviation) 26.64% 50% F 65% D
Risk Adjusted Return 26.25% 70% C- 61% D-
Market Capitalization 133.70B 63% D 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.